D.aidarbekova AİDARBEKOVA, Zh. SHALKHAROVA

Prevalence of metabolic syndrome

Nowadays there are lots of scientific publications about the problem of metabolic syndrome that is connected with early disability, cardiovascular complications. The results of European Heart Journal study showed that about 15,6 million people die from cardiovascular diseases per year, which is 29,6% of the world's total mortality. The epidemiology of metabolic syndrome with use of criteria has been studied well, the prevalence data of both the syndrome and its individual components in the most diverse regions of the planet have been accumulated. However, only a few studies take into account factors such as national characteristics, ethnic characteristics, demographic indicators (age, sex), lifestyle, occupation and nutrition in different regions, which in our opinion is necessary in planning research to determine the prevalence of this syndrome.

Anahtar Kelimeler:

metabolic syndrome, cardiovascular diseases, hypertension, smoking, obesity, morbidity, ischemic stroke, lifestyle

Prevalence of metabolic syndrome

Keywords:

metabolic syndrome, cardiovascular diseases, hypertension, smoking, obesity, morbidity, ischemic stroke, lifestyle,

PDF

___

1. Mamedov М.N., Chepurina N.A. Summarnyi serdechno-sosudistyi risk: ot teorii do praktiki. M.: D-r Reddy’s; 2008
2. Jussi Kauhanen. Reference Work Entry Encyclopedia of Behavioral Medicine Kuopio Ischemic Heart Disease Risk Factor Study pp 1143-1144 3. Abseitova S.R. Sovremennoe sostoyanie problemy serdechno-sosudistyh zabolevaniy v Yuzhno-Kazakhstanskoy oblasti. 2008g. www. cardio center. Kz
4. Vsemirnyi atlas profilaktiki serdechno-sosudistyh zabolevaniy I bor’by s nimi (VOZ, 2013g.)
5. Turdalieva B.S., Daisugurova V.Yu., Meirmanova M., Aimbetova G.E., Zhuzenov A. Kazakhskiy Natsionalnyi Meditsinskiy Universitet im. Asfendiyarova Analiz zabolevaemosti I smertnosti ot osnovnyh
6. hronicheskih neinfektsionnyh zabolevaniy naseleniya Respubliki Kazakhstan
7. World Health Statistics 2016: Monitoring health for the SDGs
8. Lakka H.M., Laaksonen D.M., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., Salonen J.T.. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Journal of American Medical Association 2002 Dec 4;288(21):2709-16.
9. Villegas R., Perry I., Don Creagh, Hinchion R., O'Halloran. Prevalence of the metabolic syndrome in middle-aged men and women. Diabetes Care 2003;26:3198-3199.
10. Empana J.P., Jouver X. Metabolic syndrome and risk of sudden cardiac death in asymptomatic subjects. Mets Insights 2006;9:11-15.
11. Meigs J.B., Wilson P.W., Nathan D.M., et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. // Diabetes.- 2003.- V. 52, №8.- P. 2160-2167
12. Chen H.J., Bai C.H., Yen W.T. et al. Influence of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke 2006; 37:1060-1064
13. Anand S.S., Yi Q., Gerstein H., et al, for the Study of Health Assessment and Risk in Ethnic Groups: Study of Health Assessment and Risk Evaluation in Aboriginal Peoples Investigators. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 2003; 108:420-425
14. Assmann G., Guerra R., Fox G., Cullen P., Schulte H., Willett D., Grundy S.M.. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol. 2007;99:541-548.
15. Qiao Q. The DECODE Study Group Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 2006;49:2837-2846.
16. Hu G., Qiao Q., Tuomilehto J., et al. Prevalence of the metabolic syndrome and its relation to all-cause mortality in nondiabetic European men and women.Arch Intern Med 2004;164:1066-76.
17. Balkau B., Charles M.A., Drivsholm T., et al.European Group For The Study Of Insulin Resistance (EGIR). Frequency of the WHO
18. metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome.Diabetes Metab. 2002;28:364-76.
19. Drygas W., Jegier A., Bednarek-Gejo A., Kwasniewska M., Dziankowska-Zaborszczyk E., Kostka T. [Physical activity volume as a key factor influencing obesity and metabolic syndrome prevalence in middle-aged men.Long-term prospective study] Przegl Lek. 2005;62 Suppl 3:8-13.
20. Kolcic I., Vorko-Jovic A., Salzer B., Smoljanovic M., Kern J., Vuletic S. Metabolic syndrome in a metapopulation of Croatian island isolates.: Croat Med J. 2006;47:585-592
21. Butnoriene J., Norkus A., Bunevicius R., Lasas L. Evaluation of diagnostic criteria for metabolic syndrome to identify insulin resistance] Medicina (Kaunas). 2006;42:455-463.
22. Onat A., Ceyhan K., Basar O., Erer B., Toprak S., Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels-a prospective and cross-sectional evaluation. Atherosclerosis. 2002;165:285-292.
23. Sy R.G. Metabolic syndrome in Asia: time for action. MesS Insights 2006; 9:4-7.
24. Mamedov M.N. Novosti meditsiny i farmatsii 10(214) 2007 25. Simonova G.I. Rasprostranennost’ metabolicheskogo sindroma I ego komponentov v Sibiri. Konferentsia “Aktual’nye voprosy diagnostiki I lecheniya metabolicheskogo sindroma”: Materialy. M
26. Polupanov A.G., Kontsevaya A.V., Mamasaidov Zh.A., Halmatov A.N., Altymysheva A.T., Dzhumagulova A.S. Rasprostranennost’ metabolicheskogo sindroma I ego komponentov sredi zhitelei Kyrgyzskoi Respubliki trudosposobnogo vozrasta. Kazanskiy meditsinskiy zhurnal 2016 tom 97 №4

A. Âsaui atyndaġy Halyk̦aralyk̦ k̦azak̦-tùrìk universitetìnìn̦ habaršysy-Cover

Yayın Aralığı: Aylık
Yayıncı: Hoca Ahmet Yesevi Uluslararası Türk-Kazak Üniversitesi

Arşiv